I. D. Stolyarov

798 total citations
26 papers, 361 citations indexed

About

I. D. Stolyarov is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, I. D. Stolyarov has authored 26 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 6 papers in Psychiatry and Mental health. Recurrent topics in I. D. Stolyarov's work include Multiple Sclerosis Research Studies (15 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Human Health and Disease (3 papers). I. D. Stolyarov is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Human Health and Disease (3 papers). I. D. Stolyarov collaborates with scholars based in Russia, United States and Italy. I. D. Stolyarov's co-authors include Krzysztof Selmaj, H. R. Sullivan, Suzanne Gazda, Edward Fox, Stephen Lake, Vesna Brinar, Ann Bass, Anton Vladić, David Margolin and Alasdair Coles and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and The Journal of Clinical Pharmacology.

In The Last Decade

I. D. Stolyarov

18 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. D. Stolyarov Russia 7 221 112 99 81 68 26 361
Reza Vosoughi Canada 9 194 0.9× 62 0.6× 107 1.1× 36 0.4× 55 0.8× 22 354
Jeffrey Palmer United States 10 303 1.4× 151 1.3× 105 1.1× 132 1.6× 95 1.4× 28 499
Lynn Stazzone United States 9 431 2.0× 81 0.7× 152 1.5× 91 1.1× 75 1.1× 10 530
Roberto Bergamaschi Italy 4 171 0.8× 85 0.8× 57 0.6× 70 0.9× 52 0.8× 7 281
Robert A Bermel United States 7 271 1.2× 39 0.3× 124 1.3× 63 0.8× 62 0.9× 12 349
Kimberly M. Winges United States 9 176 0.8× 70 0.6× 74 0.7× 29 0.4× 50 0.7× 14 353
Antonio Martı́nez-Yélamos Spain 12 279 1.3× 43 0.4× 157 1.6× 44 0.5× 79 1.2× 33 451
Ciro Florio Italy 8 142 0.6× 107 1.0× 44 0.4× 43 0.5× 34 0.5× 12 270
Alexandra Simpson United States 8 293 1.3× 46 0.4× 211 2.1× 35 0.4× 85 1.3× 14 491
Osheik Seidi United Kingdom 10 132 0.6× 111 1.0× 66 0.7× 37 0.5× 27 0.4× 17 360

Countries citing papers authored by I. D. Stolyarov

Since Specialization
Citations

This map shows the geographic impact of I. D. Stolyarov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. D. Stolyarov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. D. Stolyarov more than expected).

Fields of papers citing papers by I. D. Stolyarov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. D. Stolyarov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. D. Stolyarov. The network helps show where I. D. Stolyarov may publish in the future.

Co-authorship network of co-authors of I. D. Stolyarov

This figure shows the co-authorship network connecting the top 25 collaborators of I. D. Stolyarov. A scholar is included among the top collaborators of I. D. Stolyarov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. D. Stolyarov. I. D. Stolyarov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Катаева, Г. В., et al.. (2023). Structural epilepsy in a patient with multiple sclerosis. 28(1). 62–66.
3.
Stolyarov, I. D., et al.. (2020). The correlation between motor and cognitive dysfunction in multiple sclerosis. SHILAP Revista de lepidopterología. 14(4). 2 indexed citations
4.
Kudryavtsev, I. V., et al.. (2019). CHANGES OF INTESTINAL MICROBIOME IN MULTIPLE SCLEROSIS ARE ASSOCIATED WITH IMMUNE SHIFT AND PSYCHOEMOTIONAL DISORDERS. Medical academic journal. 19(1S). 51–54. 1 indexed citations
5.
Stolyarov, I. D., et al.. (2019). Modern conceptions about the pathogenesis of tumor-related epilepsy. Medical academic journal. 19(2). 13–25.
6.
Stolyarov, I. D., et al.. (2019). Peculiarities of epileptic process in MS patients. Practical medicine. 17(7). 67–73.
7.
Ермоленко, Е. И., et al.. (2018). The intestinal microbiota composition in patients with multiple sclerosis receiving different disease-modifying therapies DMT. S S Korsakov Journal of Neurology and Psychiatry. 118(8). 62–62. 12 indexed citations
8.
Chataway, Jeremy, Keith F. Martin, Basil Sharrack, et al.. (2018). Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis. Neurology. 90(11). e955–e962. 73 indexed citations
9.
Gavrilov, Yury V., et al.. (2018). Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients. Acta Neurologica Scandinavica. 138(5). 408–416. 22 indexed citations
10.
Stolyarov, I. D., et al.. (2017). The influence of solar and geomagnetic activity on the risk of multiple sclerosis (results of correlation and regression analysis). S S Korsakov Journal of Neurology and Psychiatry. 117(2. Vyp. 2). 42–42. 1 indexed citations
11.
Stolyarov, I. D., et al.. (2016). The role of the solar and geomagnetic activity in the etiology of multiple sclerosis: a review of the literature and prospects of research. S S Korsakov Journal of Neurology and Psychiatry. 116(2. Vyp. 2). 5–5. 1 indexed citations
12.
Stolyarov, I. D., et al.. (2016). Capabilities of positron emission tomography to study mechanisms of multiple sclerosis: own data and literature. S S Korsakov Journal of Neurology and Psychiatry. 116(2. Vyp. 2). 27–27. 2 indexed citations
13.
Катаева, Г. В., et al.. (2015). Regional metabolic changes of supraventricular tissue in patients with relapsing-remitting and secondary-progressive multiple sclerosis. S S Korsakov Journal of Neurology and Psychiatry. 115(8. Vyp. 2). 14–14. 3 indexed citations
14.
Катаева, Г. В., et al.. (2013). The Role of Changes in Glucose Metabolism in the Brain in the Formation of Cognitive Impairments in Patients with Remitting and Secondary-Progressive Multiple Sclerosis. Neuroscience and Behavioral Physiology. 43(5). 565–570. 2 indexed citations
15.
Chen, Cuiping, Verne E. Cowles, Michael Sweeney, I. D. Stolyarov, & С. Н. Иллариошкин. (2012). Pharmacokinetics and Pharmacodynamics of Gastroretentive Delivery of Levodopa/Carbidopa in Patients With Parkinson Disease. Clinical Neuropharmacology. 35(2). 67–72. 21 indexed citations
16.
Coles, Alasdair, Edward Fox, Anton Vladić, et al.. (2012). Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial. Neurology. 78(14). 1069–1078. 193 indexed citations
17.
Chen, Cuiping, et al.. (2011). Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric‐Retentive Extended‐Release Formulations in Patients With Parkinson's Disease. The Journal of Clinical Pharmacology. 52(7). 1069–1077. 7 indexed citations
18.
20.
Stolyarov, I. D., et al.. (2002). The Problem of Neuroimmunotherapy of Nervous Diseases. Human Physiology. 28(2). 246–248.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026